⌘K

Login Start Free

Home/Filings/4/0001144204-12-000737

4//SEC Filing

Hohn David C 4

Accession 0001144204-12-000737

CIK 0001318641other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:48 PM ET

Size

4.7 KB

Accession

0001144204-12-000737

Insider Transaction Report

Form 4

Period: 2012-01-04

CLEVELAND BIOLABS INCCBLI

Director

Transactions

Purchase
Common Stock, par value $0.005 per share
2012-01-04$2.98/sh+1,000$2,980→ 2,000 total

Footnotes (1)

[F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2011.

Documents

1 file

4
v244721_form4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1

filerCIK 0001523106

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 4:48 PM ET
Size: 4.7 KB

View on SEC.gov